Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Drugs of Today (Barcelona, Spain : 1998)|October 21, 2011
Recombinant tissue-type plasminogen activators: "time matters"V Kunadian, C M GibsonAnnals of Internal Medicine|June 12, 1999
Primary angioplasty compared with thrombolysis: new issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stentingC M GibsonClinical Cardiology|September 18, 2001
Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)C M Gibson, S J MarbleTrends in Cardiovascular Medicine|January 18, 2011
Limitations of cineangiography Impact of new technologies for image processing and quantitationC M Gibson, R D SafianJournal of Bacteriology|August 1, 1996
Insertional inactivation of Streptococcus pyogenes sod suggests that prtF is regulated in response to a superoxide signalC M Gibson, M G CaparonThe EMBO Journal|November 3, 1998
A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenesW R Lyon, C M Gibson, M G CaparonThe American Journal of Cardiology|November 15, 2000
Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenonA D Michaels, C M Gibson, H V BarronMolecular Microbiology|February 1, 1994
The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenesG C Fogg, C M Gibson, M G CaparonJournal of Bacteriology|January 12, 2000
Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenesC M Gibson, T C Mallett, A Claiborne, et al.Journal of the American College of Cardiology|January 1, 1993
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomyR E Kuntz, C M Gibson, M Nobuyoshi, et al.Pageof 9